文献速递结核与非结核分枝杆菌

儿童结核暴露窗口期预防性治疗的安全性与TST阳转分析

Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017.
PubMed 文献 · Emerg Infect Dis · 2019-01-01

该回顾性研究评估了2007-2017年美国休斯顿地区5岁以下结核病暴露儿童接受窗口期预防性治疗的安全性及结核菌素皮肤试验(TST)阳转比例。752名儿童接受以异烟肼为主的直接面视下治疗,无肝毒性或结核病发生,TST阳转37例(4.9%),且阳转与指示病例为患儿父母相关(OR 3.2,95%CI 1.2-8.2)。鉴于药物安全性和风险分层困难,建议对暴露幼儿启动窗口期预防的阈值应较低。

要点

  • 5岁以下结核暴露儿童接受窗口期预防性治疗未发生肝毒性或结核病。
  • TST阳转率4.9%,且与指示病例为患儿父母相关(OR 3.2)。
  • 建议对暴露幼儿启动窗口期预防的阈值应较低。

核心结论

  • 5岁以下结核暴露儿童接受窗口期预防性治疗是安全的,未发生肝毒性或结核病。
  • TST阳转率为4.9%,且与指示病例为患儿父母相关。
  • 建议对暴露幼儿启动窗口期预防的阈值应较低。

研究设计与样本

  • 回顾性研究,纳入2007-2017年美国休斯顿地区5岁以下、与成人结核病患者有暴露史的儿童。
  • 共752名儿童,其中41%与指示病例同住。
  • 纳入儿童检查、胸片无异常且结核感染检测阴性。

主要发现

  • 752名儿童接受窗口期预防,通常为异烟肼直接面视下治疗。
  • 无儿童发生肝毒性或结核病。
  • 37名(4.9%)儿童出现TST阳转。
  • TST阳转与指示病例为患儿父母相关(OR 3.2,95%CI 1.2-8.2)。
  • TST阳转与痰涂片结果、培养阳性或同住无关。

临床怎么用

  • 对5岁以下结核暴露儿童可考虑窗口期预防性治疗,因药物安全性好且风险分层困难。
  • 应关注指示病例为患儿父母的儿童,其TST阳转风险较高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In this retrospective study, we assessed the safety of window period prophylaxis and proportion of tuberculin skin test (TST) conversions in children <5 years of age who were exposed to an adult with tuberculosis disease during 2007-2017. Children included in this study had unremarkable examination and chest radiograph findings and negative test results for TB infection. In total, 752 children (41% cohabitating with the index patient) received prophylaxis during the window period, usually directly observed therapy with isoniazid. Hepatotoxicity and tuberculosis disease did not develop in any child. TST conversion occurred in 37 (4.9%) children and was associated with the index patient being the child's parent (odds ratio 3.2, 95% CI 1.2-8.2). TST conversion was not associated with sputum smear results, culture positivity, or cohabitation. Thresholds for initiation of window prophylaxis in exposed young children should be low given the safety of medication and difficulties with risk stratification.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Cruz AT, Starke JR. Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017. Emerg Infect Dis. 2019. PMID: 30789136. doi:10.3201/eid2503.181596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。